Cite
MLA Citation
Adam Pendlebury et al.. “Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600 mg/m2 in recurrent ovarian cancer.” Anti-cancer drugs, vol. 28, no. 7, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100070746314.0x000036